Laura E. Nagy received her BS in Biology in 1979 from Yale University and PhD in Nutrition in 1986 from the University of California Berkeley. She is currently a Professor of Molecular Medicine and Staff in Inflammation and Immunity and Gastroenterology and Hepatology at the Cleveland Clinic. She also holds adjunct Professor appointments at Case Western Reserve University and Cleveland State University. She is Director of the Liver Disease Research Center in the Lerner Research Institute at Cleveland Clinic. Dr.

Meaghan Phipps is a transplant hepatologist at Columbia University Irving Medical Center. Her clinical practice focuses on advanced liver disease, including the care of patients before and after liver transplantation. She has a specific interest in transplant oncology and the management of liver cancer. She also serves as Associate Program Director for Columbia and Cornell's Transplant Hepatology Fellowship.

Dr. Naga Chalasani currently serves as David W. Crabb Professor of Medicine and Vice President for Academic Affairs at Indiana University School of Medicine and Indiana University Health. He previously served as the Director of the Division of Gastroenterology and Hepatology (2007-2020) and Chair of the Department of Medicine (2020-2021, interim) at Indiana University School of Medicine.

Dr. Ariana Stuart completed her medical school training at the Oregon Health & Science University and is now completing her residency in Internal Medicine at the University of Washington. She plans to pursue a fellowship in Gastroenterology and has numerous research interests in this field, with a specific focus on patient accessibility to medical care. Additionally, she is interested in the intersection of data science and healthcare, specifically in how machine learning can be used to advance health-related research.

Veronica Nguyen, MD, is a Transplant Hepatologist at Inova Health System. She completed her Transplant Hepatology fellowship at MedStar Georgetown University Hospital. Dr. Nguyen is an active member of the American Association for the Study of Liver Diseases (AASLD) and has served on its Special Interest Group Steering Committee since 2022. She contributes to the field as a peer reviewer for journals including Transplantation, Clinical Liver Disease and ACG Case Reports Journal.

Dr. Anjana Pillai is a Professor of Medicine and Surgery at the University of Chicago. She is the Director of University of Chicago's multidisciplinary liver tumor program, interim Medical Director of the Transplant Institute and the Program Director for the ACGME accredited Transplant Hepatology Fellowship. ​

Tamar Taddei, MD, FAASLD, is Professor of Medicine and Vice Chief (Digestive Diseases) at Yale School of Medicine and Chief of Digestive Diseases at the VA Connecticut Health Care System. She serves the VA National GI and Hepatology Program as Chair of the HCC Subcommittee of the VA Hepatology Field Advisory Board. Her clinical interests focus on developing systems and programs to deliver outstanding multidisciplinary care to people with liver cancer.

Maria Reig, MD, PhD, is an internationally recognized physician-scientist specializing in liver diseases and liver cancer. She is currently Head of the Hepatic Oncology Unit at Hospital Clínic Barcelona, Head of the Barcelona Clinic Liver Cancer (BCLC) group at IDIBAPS, and Head of the Hepatic Oncology Group at CIBEREHD. She is also a member of the CIBEREHD Steering Committee. Her work focuses on advancing clinical research, innovation, and treatment strategies for patients with hepatocellular carcinoma.

I am a transplant hepatologist, clinical researcher, and Assistant Professor of Medicine at the University of North Carolina (UNC). I practice within the UNC Multidisciplinary HCC Clinic. The overall goal of my clinical work and research is to improve outcomes among patients with liver disease and hepatocellular carcinoma (HCC) by identifying risk factors for liver disease and HCC development, optimizing earlier disease detection and designing interventions to proactively address symptoms and liver-related decompensation related to HCC treatments.

Dr. Kilaru is a Clinical Associate Professor of Medicine at NYU Grossman School of Medicine, where she also serves as Program Director of the Transplant Hepatology Fellowship. She currently serves as Chair of the AASLD Inclusion and Diversity Committee.